Health outcomes and services in children with sickle cell trait, sickle cell anemia, and normal hemoglobin.
Journal
Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425
Informations de publication
Date de publication:
28 05 2019
28 05 2019
Historique:
received:
01
11
2018
accepted:
12
04
2019
entrez:
19
5
2019
pubmed:
19
5
2019
medline:
7
7
2020
Statut:
ppublish
Résumé
The health effects of sickle cell trait among children are unknown. We compared select health outcomes and health services utilization among children with sickle cell trait, sickle cell anemia (SCA), and normal hemoglobin. Newborn screening records were used to identify children with sickle cell trait and SCA born in Michigan (1997-2014) who were enrolled in Michigan Medicaid for ≥1 year from 2012 to 2014. Each select health outcome (acute otitis media, acute respiratory infections, fever, invasive pneumococcal disease, pneumonia and influenza, renal complications, spleen problems, stroke) was defined as ≥1 claim with a diagnosis code for the respective outcome within a study year. Health services utilization was summarized as counts of emergency department, inpatient, and outpatient encounters. The relationship between hemoglobin status and each health outcome or utilization was assessed by logistic or negative binomial regression with generalized estimating equations. The study population consisted of 18 257 children with sickle cell trait, 368 with SCA, and 74 523 with normal hemoglobin (227 188 total person-years). Compared with those with normal hemoglobin, children with sickle cell trait had lower odds of acute otitis media (odds ratio [OR], 0.88; 95% confidence interval [CI], 0.84-0.91), acute respiratory infections (OR, 0.94; 95% CI, 0.92-0.97), pneumonia and influenza (OR, 0.93; 95% CI, 0.87-0.99), and outpatient visits (incidence rate ratio, 0.95; 95% CI, 0.93-0.97). Children with SCA had higher or nonsignificant odds of all outcomes and types of health services utilization. These results indicate that children with sickle cell trait may not be at additional health risk for these outcomes. However, additional case-control studies may be necessary to identify rare events.
Identifiants
pubmed: 31101648
pii: bloodadvances.2018028043
doi: 10.1182/bloodadvances.2018028043
pmc: PMC6538867
doi:
Substances chimiques
Hemoglobins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1574-1580Informations de copyright
© 2019 by The American Society of Hematology.
Références
Pediatr Blood Cancer. 2009 Feb;52(2):263-7
pubmed: 18837428
Lancet. 1972 Dec 2;2(7788):1163-7
pubmed: 4117591
Am J Med Genet C Semin Med Genet. 2008 Feb 15;148C(1):15-22
pubmed: 18200513
N Engl J Med. 2008 Nov 20;359(21):2254-65
pubmed: 19020327
Am J Med. 2009 Jun;122(6):507-12
pubmed: 19393983
Am J Dis Child. 1974 Jul;128(1):58-61
pubmed: 4834985
Am J Hematol. 2012 Mar;87(3):340-6
pubmed: 22307997
Hemoglobin. 2014;38(1):28-32
pubmed: 24099594
JAMA. 1985 Apr 19;253(15):2251-4
pubmed: 3974118
Clin J Am Soc Nephrol. 2010 Jun;5(6):1015-20
pubmed: 20299376
Pediatrics. 1988 Jun;81(6):749-55
pubmed: 3368274
J Am Board Fam Pract. 1994 Mar-Apr;7(2):134-40
pubmed: 8184704
JAMA. 2014 Apr 16;311(15):1495-6
pubmed: 24604073
Br J Sports Med. 2012 Apr;46(5):325-30
pubmed: 22442191
JAMA. 2014 Nov 26;312(20):2115-25
pubmed: 25393378
Am Surg. 2016 Mar;82(3):E63-4
pubmed: 27099047
Genet Epidemiol. 1996;13(5):501-12
pubmed: 8905396
Kidney Int. 2011 Dec;80(12):1339-43
pubmed: 21849968
J Natl Med Assoc. 2006 May;98(5):704-10
pubmed: 16749645
Am J Cardiol. 2012 Oct 15;110(8):1185-8
pubmed: 22809753
J Urol. 1998 Mar;159(3):711-3
pubmed: 9474131
Biometrics. 1988 Dec;44(4):1049-60
pubmed: 3233245
Int J Gynaecol Obstet. 1990 Sep;33(1):19-21
pubmed: 1974527
JAMA Pediatr. 2016 Jun 1;170(6):550-6
pubmed: 27064406
Pediatr Blood Cancer. 2014 Mar;61(3):507-11
pubmed: 24123899
Can J Surg. 2005 Oct;48(5):377-81
pubmed: 16248136
J Natl Med Assoc. 2006 Jul;98(7):1171-4
pubmed: 16895289
Br J Haematol. 2014 Jul;166(2):165-76
pubmed: 24862308
Rev Infect Dis. 1981 Mar-Apr;3(2):246-53
pubmed: 7020043
J Community Hosp Intern Med Perspect. 2014 Nov 25;4(5):25418
pubmed: 25432648
Am J Emerg Med. 2013 Feb;31(2):446.e1-3
pubmed: 22944537
J Am Med Assoc. 1954 Jan 9;154(2):111-3
pubmed: 13108677
Lancet. 1976 Oct 9;2(7989):784-6
pubmed: 61453
Conn Med. 2007 Jan;71(1):9-12
pubmed: 17288099
Stroke. 2014 Oct;45(10):2863-7
pubmed: 25139879
JAMA Neurol. 2018 Jul 1;75(7):802-807
pubmed: 29710269
Wilderness Environ Med. 2008 Winter;19(4):318-20
pubmed: 19099334
Pediatrics. 2018 Mar;141(3):
pubmed: 29437860
J Natl Med Assoc. 2012 May-Jun;104(5-6):299-304
pubmed: 22973679
Am J Hematol. 2005 Dec;80(4):262-70
pubmed: 16315251
Blood. 2007 Aug 1;110(3):908-12
pubmed: 17409269
Acad Pediatr. 2014 Sep-Oct;14(5 Suppl):S61-7
pubmed: 24882379
J Urol. 2001 Sep;166(3):803-11
pubmed: 11490223
Am J Surg Pathol. 1995 Jan;19(1):1-11
pubmed: 7528470
Hematology Am Soc Hematol Educ Program. 2015;2015:160-7
pubmed: 26637716
Blood. 1998 Jan 1;91(1):288-94
pubmed: 9414296
BMJ Open. 2017 Mar 29;7(3):e012665
pubmed: 28360235
Biom J. 2018 May;60(3):431-449
pubmed: 29292533
J Pediatr Hematol Oncol. 1998 Nov-Dec;20(6):528-33
pubmed: 9856672
Am J Prev Med. 2010 Apr;38(4 Suppl):S512-21
pubmed: 20331952
Lancet. 2004 Oct 9-15;364(9442):1343-60
pubmed: 15474138